1. Home
  2. TLSI

TLSI

TriSalus Life Sciences Inc.

Logo TriSalus Life Sciences Inc.

Health Care

Medical Specialities

Nasdaq

as 04-17-2024 11:00am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.

Founded: 2010 Country:
United States
United States
Employees: N/A City: WESTMINSTER
Market Cap: 283.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 31.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.73 EPS Growth: N/A
52 Week Low/High: $3.32 - $12.83 Next Earning Date: 05-15-2024
Revenue: $18,511,000 Revenue Growth: 49.31%
Revenue Growth (this year): 68.86% Revenue Growth (next year): 57.59%

Share on Social Networks: